Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015, Article ID 843058, 14 pages
http://dx.doi.org/10.1155/2015/843058
Research Article

Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34pos Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction

1Department of Gastroenterology, Hepatology and Endocrinology, RG Translational Hepatology and Stem Cell Biology (OE 6817), Cluster-of-Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Street, 30625 Hannover, Germany
2Department of Transfusion Medicine, Cell Therapy and Hemostaseology, Ludwig-Maximilian University Hospital, Max-Lebsche-Platz 32 A, 81377 Munich, Germany
3DRK Institute of Transfusion Medicine and Immune Hematology, Frankfurt, Germany
4Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany

Received 2 March 2015; Revised 14 May 2015; Accepted 25 May 2015

Academic Editor: Igor Slukvin

Copyright © 2015 Mohsen Moslem et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Sutton and T. L. Bonfield, “Stem cells: innovations in clinical applications,” Stem Cells International, vol. 2014, Article ID 516278, 9 pages, 2014. View at Publisher · View at Google Scholar
  2. A. Ludwig, R. Saffrich, V. Eckstein et al., “Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by plerixafor,” Cytotherapy, vol. 16, no. 1, pp. 111–121, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Oodi, M. Noruzinia, M. H. Roudkenar et al., “Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells,” Hematology, vol. 17, no. 6, pp. 334–340, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Sato, K. Ozaki, I. Oh et al., “Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells,” Blood, vol. 109, no. 1, pp. 228–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Le Blanc, I. Rasmusson, C. Götherström et al., “Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes,” Scandinavian Journal of Immunology, vol. 60, no. 3, pp. 307–315, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Ren, L. Zhang, X. Zhao et al., “Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide,” Cell Stem Cell, vol. 2, no. 2, pp. 141–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Yu, M. A. Vodyanik, K. Smuga-Otto et al., “Induced pluripotent stem cell lines derived from human somatic cells,” Science, vol. 318, no. 5858, pp. 1917–1920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Groß, M. Sgodda, M. Rasche et al., “Improved generation of patient-specific induced pluripotent stem cells using a chemically-defined and matrigel-based approach,” Current Molecular Medicine, vol. 13, no. 5, pp. 765–776, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Zaehres, G. Kögler, M. J. Arauzo-Bravo et al., “Induction of pluripotency in human cord blood unrestricted somatic stem cells,” Experimental Hematology, vol. 38, no. 9, pp. 809–818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Eberle, M. Moslem, R. Henschler, and T. Cantz, “Engineered MSCs from patient-specific iPS cells,” in Mesenchymal Stem Cells—Basics and Clinical Application II, vol. 130 of Advances in Biochemical Engineering/Biotechnology, pp. 1–17, Springer, Berlin, Germany, 2013. View at Publisher · View at Google Scholar
  12. L. Sánchez, I. Gutierrez-Aranda, G. Ligero et al., “Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease,” Stem Cells, vol. 29, no. 2, pp. 251–262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-Q. Sun, M.-X. Deng, J. He et al., “Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice,” Stem Cells, vol. 30, no. 12, pp. 2692–2699, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Moslem, M. R. Valojerdi, B. Pournasr, A. Muhammadnejad, and H. Baharvand, “Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure,” Cell Transplantation, vol. 22, no. 10, pp. 1785–1799, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Q. Lian, Y. Zhang, J. Zhang et al., “Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice,” Circulation, vol. 121, no. 9, pp. 1113–1123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Jung, G. Bauer, and J. A. Nolta, “Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products,” Stem Cells, vol. 30, no. 1, pp. 42–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Hynes, D. Menicanin, J. Han et al., “Mesenchymal stem cells from iPS cells facilitate periodontal regeneration,” Journal of Dental Research, vol. 92, no. 9, pp. 833–839, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Wagner, F. Wein, A. Seckinger et al., “Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood,” Experimental Hematology, vol. 33, no. 11, pp. 1402–1416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Torensma, H.-J. Prins, E. Schrama et al., “The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells,” Stem Cells and Development, vol. 22, no. 7, pp. 1086–1096, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Pachón-Peña, G. Yu, A. Tucker et al., “Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles,” Journal of Cellular Physiology, vol. 226, no. 3, pp. 843–851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Shen, A. Wei, S. Whittaker et al., “The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro,” Journal of Cellular Biochemistry, vol. 109, no. 2, pp. 406–416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Zou, X. Zou, L. Chen et al., “Multilineage differentiation of porcine bone marrow stromal cells associated with specific gene expression pattern,” Journal of Orthopaedic Research, vol. 26, no. 1, pp. 56–64, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Karystinou, F. Dell'Accio, T. B. A. Kurth et al., “Distinct mesenchymal progenitor cell subsets in the adult human synovium,” Rheumatology, vol. 48, no. 9, pp. 1057–1064, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Warlich, J. Kuehle, T. Cantz et al., “Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming,” Molecular Therapy, vol. 19, no. 4, pp. 782–789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Haase, R. Olmer, K. Schwanke et al., “Generation of induced pluripotent stem cells from human cord blood,” Cell Stem Cell, vol. 5, no. 4, pp. 434–441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Rüster, S. Göttig, R. J. Ludwig et al., “Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells,” Blood, vol. 108, no. 12, pp. 3938–3944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Kern, H. Eichler, J. Stoeve, H. Klüter, and K. Bieback, “Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue,” Stem Cells, vol. 24, no. 5, pp. 1294–1301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Sgodda, S. Möbus, J. Hoepfner et al., “Improved hepatic differentiation strategies for human induced pluripotent stem cells,” Current Molecular Medicine, vol. 13, no. 5, pp. 842–855, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. M. DiMarino, A. I. Caplan, and T. L. Bonfield, “Mesenchymal stem cells in tissue repair,” Frontiers in Immunology, vol. 4, article 102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. K.-R. Yu and K.-S. Kang, “Aging-related genes in mesenchymal stem cells: a mini-review,” Gerontology, vol. 59, no. 6, pp. 557–563, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. C. L. Radtke, R. Nino-Fong, B. P. Esparza Gonzalez, H. Stryhn, and L. A. McDuffee, “Characterization and osteogenic potential of equine muscle tissue- and periosteal tissue-derived mesenchymal stem cells in comparison with bone marrow- and adipose tissue-derived mesenchymal stem cells,” American Journal of Veterinary Research, vol. 74, no. 5, pp. 790–800, 2013. View at Google Scholar
  33. S. J. Morrison and A. C. Spradling, “Stem cells and niches: mechanisms that promote stem cell maintenance throughout life,” Cell, vol. 132, no. 4, pp. 598–611, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Wilson and A. Trumpp, “Bone-marrow haematopoietic-stem-cell niches,” Nature Reviews Immunology, vol. 6, no. 2, pp. 93–106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Arai, A. Hirao, M. Ohmura et al., “Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche,” Cell, vol. 118, no. 2, pp. 149–161, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. K. W. Orford and D. T. Scadden, “Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation,” Nature Reviews Genetics, vol. 9, no. 2, pp. 115–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Zhang, C. Niu, L. Ye et al., “Identification of the haematopoietic stem cell niche and control of the niche size,” Nature, vol. 425, no. 6960, pp. 836–841, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Sugiyama, H. Kohara, M. Noda, and T. Nagasawa, “Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches,” Immunity, vol. 25, no. 6, pp. 977–988, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Milazzo, F. Vulcano, A. Barca et al., “Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice,” European Journal of Haematology, vol. 93, no. 5, pp. 384–391, 2014. View at Publisher · View at Google Scholar
  40. S. Nishiwaki, T. Nakayama, S. Saito et al., “Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis,” International Journal of Hematology, vol. 96, no. 3, pp. 295–300, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Jing, A.-V. Fonseca, N. Alakel et al., “Hematopoietic stem cells in co-culture with mesenchymal stromal cells—modeling the niche compartments in vitro,” Haematologica, vol. 95, no. 4, pp. 542–550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. B. Sharma, L. S. Limaye, and V. P. Kale, “Mimicking the functional hematopoietic stem cell niche in vitro: recapitulation of marrow physiology by hydrogel-based three-dimensional cultures of mesenchymal stromal cells,” Haematologica, vol. 97, no. 5, pp. 651–660, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Wagner, C. Roderburg, F. Wein et al., “Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors,” Stem Cells, vol. 25, no. 10, pp. 2638–2647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Keating, “Mesenchymal stromal cells: new directions,” Cell Stem Cell, vol. 10, no. 6, pp. 709–716, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Uccelli, L. Moretta, and V. Pistoia, “Mesenchymal stem cells in health and disease,” Nature Reviews Immunology, vol. 8, no. 9, pp. 726–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. B. R. Blazar, W. J. Murphy, and M. Abedi, “Advances in graft-versus-host disease biology and therapy,” Nature Reviews Immunology, vol. 12, no. 6, pp. 443–458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Liu, R. Yang, and S. Shi, “Systemic infusion of mesenchymal stem cells improves cell-based bone regeneration via upregulation of regulatory T cells,” Tissue Engineering Part A, vol. 21, no. 3-4, pp. 498–509, 2015. View at Publisher · View at Google Scholar
  48. M. Giuliani, N. Oudrhiri, Z. M. Noman et al., “Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery,” Blood, vol. 118, no. 12, pp. 3254–3262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener, and D. Dilloo, “Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation,” Blood, vol. 103, no. 12, pp. 4619–4621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. W. T. Tse, J. D. Pendleton, W. M. Beyer, M. C. Egalka, and E. C. Guinan, “Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation,” Transplantation, vol. 75, no. 3, pp. 389–397, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Krampera, S. Glennie, J. Dyson et al., “Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide,” Blood, vol. 101, no. 9, pp. 3722–3729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Saldanha-Araujo, R. Haddad, K. C. R. Malmegrim de Farias et al., “Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling,” Journal of Cellular and Molecular Medicine, vol. 16, no. 6, pp. 1232–1244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Luz-Crawford, M. Kurte, J. Bravo-Alegría et al., “Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells,” Stem Cell Research & Therapy, vol. 4, no. 3, article 65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Nazarov, J. L. Surdo, S. R. Bauer, and C.-H. Wei, “Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro,” Stem Cell Research and Therapy, vol. 4, no. 5, article 128, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Dorronsoro, I. Ferrin, J. M. Salcedo et al., “Human mesenchymal stromal cells modulate T-cell responses through TNF-alpha-mediated activation of NF-kappaB,” European Journal of Immunology, vol. 44, no. 2, pp. 480–488, 2014. View at Publisher · View at Google Scholar · View at Scopus